- Home
- IMMP vs HLLY Comparison
IMMP vs HLLY Comparison
Compare IMMP & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- HLLY
- Stock Information
- Founded
- IMMP 1987
- HLLY 1903
- Country
- IMMP Australia
- HLLY United States
- Employees
- IMMP N/A
- HLLY N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- HLLY Auto Parts:O.E.M.
- Sector
- IMMP Health Care
- HLLY Consumer Discretionary
- Exchange
- IMMP Nasdaq
- HLLY Nasdaq
- Market Cap
- IMMP 304.0M
- HLLY 348.6M
- IPO Year
- IMMP N/A
- HLLY N/A
- Fundamental
- Price
- IMMP $2.17
- HLLY $2.76
- Analyst Decision
- IMMP Buy
- HLLY Strong Buy
- Analyst Count
- IMMP 2
- HLLY 6
- Target Price
- IMMP $8.50
- HLLY $6.63
- AVG Volume (30 Days)
- IMMP 147.6K
- HLLY 468.1K
- Earning Date
- IMMP 12-27-2024
- HLLY 11-08-2024
- Dividend Yield
- IMMP N/A
- HLLY N/A
- EPS Growth
- IMMP N/A
- HLLY N/A
- EPS
- IMMP N/A
- HLLY 0.13
- Revenue
- IMMP $2,563,302.00
- HLLY $617,877,000.00
- Revenue This Year
- IMMP N/A
- HLLY N/A
- Revenue Next Year
- IMMP $10.84
- HLLY $3.82
- P/E Ratio
- IMMP N/A
- HLLY $21.03
- Revenue Growth
- IMMP 9.59
- HLLY N/A
- 52 Week Low
- IMMP $1.66
- HLLY $2.29
- 52 Week High
- IMMP $3.34
- HLLY $5.23
- Technical
- Relative Strength Index (RSI)
- IMMP 55.07
- HLLY 46.81
- Support Level
- IMMP $2.00
- HLLY $2.70
- Resistance Level
- IMMP $2.39
- HLLY $2.89
- Average True Range (ATR)
- IMMP 0.13
- HLLY 0.12
- MACD
- IMMP 0.01
- HLLY -0.01
- Stochastic Oscillator
- IMMP 54.17
- HLLY 24.07
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About HLLY Holley Inc.
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.